New findings offer improved therapy of early-stage, BRCA mutation-associated breast cancer

Results were released this week on a new treatment with the potential to improve the outcomes for patients with hereditary BRCA mutations and high-risk, early-stage breast cancer. These results represent the first time a drug that blocks cancer cells from repairing their DNA (called a PARP inhibitor) has been shown to significantly reduce the risk …

Researchers yield new insights into origins of synovial sarcoma

A new study published today in Cancer Discovery, a journal of the American Association for Cancer Research, reports findings that may change the understanding of how synovial sarcoma develops and spreads. The study, headed by Kevin B. Jones, MD, a surgeon-scientist, and Bradley R. Cairns, Ph.D., cancer researcher and chief academic officer, both at Huntsman …